Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2018 · 10-Q
Revenue$327.00K$327.00K+227.1% vs Q2 2017 Net Income-$3.60M-$3.60MN/M vs Q2 2017 EPS Diluted-$0.03-$0.03N/M vs Q2 2017 Gross Profit$126,000+374.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,057,000N/M Margins · derivedGross margin38.5%+11.9 pt vs Q2 2017
Operating margin-497.9%+968.7 pt vs Q2 2017
Net margin-1100.9%+1473.8 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end